Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Long Chuang

Showing results (91-100 of 456) with videos related to

Pageof 46
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 18, 2005
Safety of fine-needle aspiration in patients with small hepatocellular carcinomaChu-Wen Wang, Zu-Yau Lin, Wan-Long Chuang, et al.
The Kaohsiung Journal of Medical Sciences|January 21, 2015
Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilutionTa-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of ColchicineZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Antiviral Research|October 31, 2001
The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patientsChia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 20, 2018
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BChao-Wei Hsu, Wei-Wen Su, Chuan-Mo Lee, et al.
Antiviral Therapy|February 17, 2007
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in TaiwanMing-Lung Yu, Shi-Ming Lin, Wan-Long Chuang, et al.
Antiviral Research|June 16, 2004
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factorsMing-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Medicine|March 26, 2016
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese PatientsChi-Ming Tai, Chih-Kun Huang, Hung-Pin Tu, et al.
Scientific Reports|October 12, 2018
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antiviralsChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
European Journal of Gastroenterology & Hepatology|October 12, 2018
Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsiesTa-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, et al.
Pageof 46

Showing results (91-100 of 456) with videos related to

Sort By:
Pageof 46
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 18, 2005
Safety of fine-needle aspiration in patients with small hepatocellular carcinomaChu-Wen Wang, Zu-Yau Lin, Wan-Long Chuang, et al.
The Kaohsiung Journal of Medical Sciences|January 21, 2015
Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilutionTa-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of ColchicineZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Antiviral Research|October 31, 2001
The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patientsChia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 20, 2018
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BChao-Wei Hsu, Wei-Wen Su, Chuan-Mo Lee, et al.
Antiviral Therapy|February 17, 2007
A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in TaiwanMing-Lung Yu, Shi-Ming Lin, Wan-Long Chuang, et al.
Antiviral Research|June 16, 2004
A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factorsMing-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Medicine|March 26, 2016
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese PatientsChi-Ming Tai, Chih-Kun Huang, Hung-Pin Tu, et al.
Scientific Reports|October 12, 2018
Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antiviralsChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
European Journal of Gastroenterology & Hepatology|October 12, 2018
Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsiesTa-Ya Lin, Ming-Lun Yeh, Chung-Feng Huang, et al.
Pageof 46